The Tale of TILs in Breast Cancer: A Report from the International Immuno-Oncology Biomarker Working Group

By
Justin.choi
-
0
12
The authors discuss the biological understanding of tumor-infiltrating lymphocytes (TILs), their analytical and clinical validity and efforts towards the clinical utility in breast cancer, and the current status of programmed death-ligand 1and TIL testing across different continents.
[npj Breast Cancer]

Sorry, but the selected Zotpress account can't be found.

Full Article